Developer docs
API playgroundTry for free, no card

Search company profiles

Canchemia Inc.

Full company profile

uuid00yp5as

Namestring
Canchemia Inc.
Legal namestring
Canchemia Inc.
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Canchemia Inc. (also branded CanChemia) is a privately held Canadian company headquartered at Unit 609, 5 Liszt Gate, Toronto, Ontario. The company supplies raw materials, intermediates, active pharmaceutical ingredients (APIs), and fine chemicals to the pharmaceutical and specialty chemical industries in North America. Its stated value proposition is competitive pricing combined with quality and timeline reliability, supported by an integrated supply chain that pairs in-house developmental laboratories, pilot plants, and commercial manufacturing capabilities with a dedicated sourcing team in China. The company publicly commits to Responsible Care principles for safe chemical handling and processing.

Canchemia operates a direct B2B distribution model, selling chemicals through direct sales to pharmaceutical and specialty chemical buyers across North America. Its primary digital presence is on the LookChem B2B chemical marketplace, where it currently lists two products: 5-Ethyl-2-pyridineethanol (CAS 5223-6-3) and Thiazolidine, 2,2-dimethyl-, hydrochloride (CAS 822-44-6), both pharmaceutical intermediates with documented CAS numbers, molecular formulas, and 99% purity specifications. Pricing is handled through direct supplier contact rather than published tiers, and minimum order quantities and payment terms are not publicly disclosed.

The company's underlying platform architecture is its integrated manufacturing-plus-sourcing structure: developmental labs and pilot plants enable process development and small-batch work, while commercial manufacturing and the China sourcing team enable scale and cost-competitive procurement. Ownership appears to be independent and closely held, with no institutional investors, parent companies, or venture backing disclosed in the source material. Revenue, headcount, founding date, certifications, and management team details are not publicly documented in the inputs provided.

Short descriptiontext

Canchemia Inc. is a privately held Canadian B2B chemical supplier that provides raw materials, intermediates, APIs, and fine chemicals to pharmaceutical and specialty chemical buyers across North America, leveraging in-house laboratories, pilot plants, commercial manufacturing, and a China-based sourcing team.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical intermediates, active pharmaceutical ingredients, specialty chemical supply, fine chemicals distribution, chemical raw materials
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical Raw Materials
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Chemical Product Sales
TypeOne Time License
Description

Revenue generated from the sale of raw materials, intermediates, Active Pharmaceutical Ingredients (APIs), and fine chemicals to pharmaceutical and specialty chemical industry customers in North America.

canchemia.lookchem.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Canchemia Inc. is a Canadian supplier of raw materials, intermediates, Active Pharmaceutical Ingredients (APIs), and fine chemicals serving the pharmaceutical and specialty chemical industries in North America. The company combines in-house developmental laboratories, pilot plants, and commercial manufacturing facilities with a China-based sourcing team to deliver products with superior timeline, quality, and pricing. It operates under Responsible Care principles for safe chemical handling and processing.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Canchemia Inc. operates as a chemical raw materials supplier offering a focused portfolio of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company supplies two main chemical compounds: 5-Ethyl-2-pyridineethanol (CAS 5223-6-3) and Thiazolidine, 2,2-dimethyl-, hydrochloride (CAS 822-44-6). These products are sold as raw materials and intermediates for the pharmaceutical and specialty chemical industries in North America, distributed through the LookChem marketplace platform.

Product and service2 records
15-Ethyl-2-pyridineethanol
CategoryChemical Compound
Description

Pharmaceutical intermediate with CAS No. 5223-6-3 and molecular formula C9H13NO. Sold as a raw material for pharmaceutical and specialty chemical manufacturing, with 99% purity and packaging according to client requirements.

2Thiazolidine, 2,2-dimethyl-, hydrochloride
CategoryChemical Compound
Description

Pharmaceutical intermediate with CAS No. 822-44-6 and molecular formula C5H12ClNS. Sold at 99% purity as a raw material for pharmaceutical manufacturing, with packaging per client requirement and transportation by sea or air.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Internal sourcing team based in China that establishes and maintains solid cooperation with overseas customers and suppliers to support the company's chemical supply operations.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Online-first chemicals supplier offering intermediates, APIs, and fine chemicals to research and industrial buyers. Comparable marketplace-led GTM and pharmaceutical intermediate product mix.

TypeBroad incumbent
Description

Specialty chemicals company with pharmaceutical materials, catalysts, and fine chemicals offerings. Comparable product category but operates as a diversified incumbent serving global pharma and industrial customers.

TypeDirect peer
Description

Supplier of research chemicals, biochemicals, and pharmaceutical intermediates. Comparable B2B distribution to pharma and life sciences buyers with broad chemical intermediate offerings.

TypeOthers
Description

Contract development and manufacturing organization (CDMO) offering API and intermediate supply to the pharma industry. Adjacent rather than directly competitive - represents the type of integrated service model Canchemia could evolve toward.

TypeBroad incumbent
Description

Global incumbent in research and specialty chemicals, including pharmaceutical intermediates and APIs under the Sigma-Aldrich brand. Overlaps with Canchemia on product category but serves far broader portfolio and geography.

TypeBroad incumbent
Description

Diversified life sciences and laboratory products supplier offering chemicals, intermediates, and pharma services. Competes with Canchemia for pharma and specialty chemical procurement budgets but as part of a much wider portfolio.

TypeDirect peer
Description

Canadian supplier of specialty organic chemicals, including pharmaceutical intermediates and reference standards. Highly comparable to Canchemia in geography, product category, and customer base in North American pharma R&D.

TypeDirect peer
Description

Global specialty chemicals supplier with deep catalog of pharmaceutical intermediates, APIs, and fine chemicals. Directly comparable in product category, customer base, and B2B distribution model.

TypeDirect peer
Description

US-based supplier of chemical building blocks, intermediates, and APIs to pharmaceutical and biotech customers. Overlaps with Canchemia on intermediate/API supply and pharma buyer base.

TypeBroad incumbent
Description

Global chemical giant with significant pharmaceutical ingredients and intermediates business. Overlaps with Canchemia on fine chemicals and APIs but operates at vastly larger scale with broad product portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Canchemia Inc.

Pharmaceutical Raw Materialscanchemia.lookchem.com

Canchemia Inc. is a privately held Canadian B2B chemical supplier that provides raw materials, intermediates, APIs, and fine chemicals to pharmaceutical and specialty chemical buyers across North America, leveraging in-house laboratories, pilot plants, commercial manufacturing, and a China-based sourcing team.

What Canchemia Inc. does

Canchemia Inc. (also branded CanChemia) is a privately held Canadian company headquartered at Unit 609, 5 Liszt Gate, Toronto, Ontario. The company supplies raw materials, intermediates, active pharmaceutical ingredients (APIs), and fine chemicals to the pharmaceutical and specialty chemical industries in North America. Its stated value proposition is competitive pricing combined with quality and timeline reliability, supported by an integrated supply chain that pairs in-house developmental laboratories, pilot plants, and commercial manufacturing capabilities with a dedicated sourcing team in China. The company publicly commits to Responsible Care principles for safe chemical handling and processing.

Canchemia operates a direct B2B distribution model, selling chemicals through direct sales to pharmaceutical and specialty chemical buyers across North America. Its primary digital presence is on the LookChem B2B chemical marketplace, where it currently lists two products: 5-Ethyl-2-pyridineethanol (CAS 5223-6-3) and Thiazolidine, 2,2-dimethyl-, hydrochloride (CAS 822-44-6), both pharmaceutical intermediates with documented CAS numbers, molecular formulas, and 99% purity specifications. Pricing is handled through direct supplier contact rather than published tiers, and minimum order quantities and payment terms are not publicly disclosed.

The company's underlying platform architecture is its integrated manufacturing-plus-sourcing structure: developmental labs and pilot plants enable process development and small-batch work, while commercial manufacturing and the China sourcing team enable scale and cost-competitive procurement. Ownership appears to be independent and closely held, with no institutional investors, parent companies, or venture backing disclosed in the source material. Revenue, headcount, founding date, certifications, and management team details are not publicly documented in the inputs provided.

Canchemia Inc. firmographics

Firmographics
Name
Canchemia Inc.
Legal name
Canchemia Inc.
Website
https://canchemia.lookchem.com
Company type
Private
Operating status
Operating
Short description
Canchemia Inc. is a privately held Canadian B2B chemical supplier that provides raw materials, intermediates, APIs, and fine chemicals to pharmaceutical and specialty chemical buyers across North America, leveraging in-house laboratories, pilot plants, commercial manufacturing, and a China-based sourcing team.
Ownership category
akta.pro rank

Where Canchemia Inc. is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Canchemia Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Chemical Product Sales: Revenue generated from the sale of raw materials, intermediates, Active Pharmaceutical Ingredients (APIs), and fine chemicals to pharmaceutical and specialty chemical industry customers in North America.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Canchemia Inc. product offering

Product offering

Core offering

Canchemia Inc. is a Canadian supplier of raw materials, intermediates, Active Pharmaceutical Ingredients (APIs), and fine chemicals serving the pharmaceutical and specialty chemical industries in North America. The company combines in-house developmental laboratories, pilot plants, and commercial manufacturing facilities with a China-based sourcing team to deliver products with superior timeline, quality, and pricing. It operates under Responsible Care principles for safe chemical handling and processing.

Product overview

Canchemia Inc. operates as a chemical raw materials supplier offering a focused portfolio of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company supplies two main chemical compounds: 5-Ethyl-2-pyridineethanol (CAS 5223-6-3) and Thiazolidine, 2,2-dimethyl-, hydrochloride (CAS 822-44-6). These products are sold as raw materials and intermediates for the pharmaceutical and specialty chemical industries in North America, distributed through the LookChem marketplace platform.

Differentiator

Problem solved

Functional benefit

Products and services

  • 5-Ethyl-2-pyridineethanol Pharmaceutical intermediate with CAS No. 5223-6-3 and molecular formula C9H13NO. Sold as a raw material for pharmaceutical and specialty chemical manufacturing, with 99% purity and packaging according to client requirements.
  • Thiazolidine, 2,2-dimethyl-, hydrochloride Pharmaceutical intermediate with CAS No. 822-44-6 and molecular formula C5H12ClNS. Sold at 99% purity as a raw material for pharmaceutical manufacturing, with packaging per client requirement and transportation by sea or air.

Companies that use Canchemia Inc.

Customer profile

Segments2 records

Ideal customer profiles2 records

Canchemia Inc. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Canchemia Inc. partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • China Sourcing TeamcoreOthersInternal sourcing team based in China that establishes and maintains solid cooperation with overseas customers and suppliers to support the company's chemical supply operations.

Scale indicators1 record

Recent moves4 records

Expansion highlights2 records

Canchemia Inc. competitors and assessment

Company assessment

Direct peers

  • Alfa Chemistry: Online-first chemicals supplier offering intermediates, APIs, and fine chemicals to research and industrial buyers. Comparable marketplace-led GTM and pharmaceutical intermediate product mix.
  • Santa Cruz Biotechnology: Supplier of research chemicals, biochemicals, and pharmaceutical intermediates. Comparable B2B distribution to pharma and life sciences buyers with broad chemical intermediate offerings.
  • Toronto Research Chemicals: Canadian supplier of specialty organic chemicals, including pharmaceutical intermediates and reference standards. Highly comparable to Canchemia in geography, product category, and customer base in North American pharma R&D.
  • TCI Chemicals (Tokyo Chemical Industry): Global specialty chemicals supplier with deep catalog of pharmaceutical intermediates, APIs, and fine chemicals. Directly comparable in product category, customer base, and B2B distribution model.
  • Combi-Blocks: US-based supplier of chemical building blocks, intermediates, and APIs to pharmaceutical and biotech customers. Overlaps with Canchemia on intermediate/API supply and pharma buyer base.

Broad incumbents

  • Johnson Matthey: Specialty chemicals company with pharmaceutical materials, catalysts, and fine chemicals offerings. Comparable product category but operates as a diversified incumbent serving global pharma and industrial customers.
  • Sigma-Aldrich (Merck KGaA): Global incumbent in research and specialty chemicals, including pharmaceutical intermediates and APIs under the Sigma-Aldrich brand. Overlaps with Canchemia on product category but serves far broader portfolio and geography.
  • Thermo Fisher Scientific: Diversified life sciences and laboratory products supplier offering chemicals, intermediates, and pharma services. Competes with Canchemia for pharma and specialty chemical procurement budgets but as part of a much wider portfolio.
  • BASF: Global chemical giant with significant pharmaceutical ingredients and intermediates business. Overlaps with Canchemia on fine chemicals and APIs but operates at vastly larger scale with broad product portfolio.

Others

  • Pfizer CentreOne: Contract development and manufacturing organization (CDMO) offering API and intermediate supply to the pharma industry. Adjacent rather than directly competitive - represents the type of integrated service model Canchemia could evolve toward.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

Canchemia Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Canchemia Inc. leadership team

Management profile

Number of profiles

Profiles1 record

Canchemia Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Canchemia Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canchemia Inc.

What does Canchemia Inc. do?

Canchemia Inc. is a Canadian supplier of raw materials, intermediates, Active Pharmaceutical Ingredients (APIs), and fine chemicals serving the pharmaceutical and specialty chemical industries in North America. The company combines in-house developmental laboratories, pilot plants, and commercial manufacturing facilities with a China-based sourcing team to deliver products with superior timeline, quality, and pricing. It operates under Responsible Care principles for safe chemical handling and processing.

When was Canchemia Inc. founded?

Canchemia Inc. was founded in -1.

Where is Canchemia Inc. based?

Canchemia Inc. is headquartered in Toronto, Canada, in the North America region.

How does Canchemia Inc. make money?

One revenue line is on record: chemical Product Sales.

Who are Canchemia Inc.'s main competitors?

Direct peers on record are Alfa Chemistry, Santa Cruz Biotechnology, Toronto Research Chemicals, TCI Chemicals (Tokyo Chemical Industry) and Combi-Blocks. Broad incumbents are Johnson Matthey, Sigma-Aldrich (Merck KGaA), Thermo Fisher Scientific and BASF. Pfizer CentreOne is listed as an others.

Does Canchemia Inc. have an API?

No public API is recorded for Canchemia Inc..

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales